effects of ursodeoxycholic acid on neonatal indirect jundice
Phase 3
- Conditions
- Indirect hyperbilirubinemia.Other disorders of bilirubin metabolism
- Registration Number
- IRCT20171124037615N1
- Lead Sponsor
- Zabol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Individuals with indirect pathologic Hyperbilirubinemia
A 3-5 day baby with a birth weight of 2.5 to 4 kg fed on breast milk- Tobol
bilirubin levels between 12 to 20 mg / dl and direct bilirubin levels <2 mg / dl
Exclusion Criteria
Having any of the liver, metabolic, sepsis diseases
The use of any other drug that has an effect on the level of bilirubin
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total bilirubin. Timepoint: Every 24 hours. Method of measurement: ??Auto analyzer.
- Secondary Outcome Measures
Name Time Method Direct bilirubin. Timepoint: every 24 hour. Method of measurement: Autoanalyzer.